Fenwal, a Fresenius Kabi company, announced today it has received 60601-1 3rd edition certification for the Aurora™ plasmapheresis system designed for collection of plasma. 60601-1 3rd edition is the ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)-- Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the ...
LAKE ZURICH, Ill., Dec. 16, 2010 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today the U.S.
LAKE ZURICH, Ill., Aug. 19 Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)-- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has received CE ...
Fenwal, a global medical technology company focused on improving blood collection, to ensure the availability, safety and effectiveness of blood components, received FDA clearance for wireless data ...
The U.S. Food and Drug Administration has cleared for marketing a new source plasma collection system developed by Fenwal, Inc., the company announced today. Called the Aurora TM plasmapheresis system ...
HemaTerra Technologies, provider of end-to-end operational software products to blood centers, announced that it will work with Fenwal Inc. to develop a companion product to HemaConnect, the ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results